Seattle Children's Hospital · company speakers →
Dr. Juliane Gust will provide updates on risk prediction and management of immune effector cell associated neurotoxicity syndrome (ICANS). We will discuss the different clinical presentations of ICANS, the evidence base for graded monitoring and intervention approaches, and the expanded spectrum of neurologic toxicities in cell based immunotherapy.
Is this you? Claim this profile →
No public contact links on file.
Sourcing speakers for your event?
Browse the speaker directory →